FDA updates Novo Nordisk's Ozempic drug label with side effect alert
The US health authority, FDA, revealed that it has updated the label for Novo’s Ozempic, warning of the potential side effect of intestinal blockage, Fierce Pharma writes.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.